Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures

ABSTRACT: Background: Falcipain 2 (FP-2) is the hemoglobin-degrading cysteine protease of Plasmodium falciparum most extensively targeted to develop novel antimalarials. However, no commercial antimalarial drugs based on FP-2 inhibition are available yet due to the low selectivity of most FP-2 inhib...

Full description

Autores:
Hernández González, Jorge Enrique
Salas Sarduy, Emir
Hernández Ramírez, Luisa Fernanda
Pascual, María José
Álvarez, Diego
Pabón Vidal, Adriana
Leitea, Vitor Barbanti
Pascuttie, Pedro
Valiente, Pedro
Tipo de recurso:
Article of investigation
Fecha de publicación:
2018
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/26424
Acceso en línea:
http://hdl.handle.net/10495/26424
Palabra clave:
Plasmodium falciparum
Simulación de Dinámica Molecular
Molecular Dynamics Simulation
Antimaláricos
Antimalarials
Cisteína Endopeptidasas
Cysteine Endopeptidases
Concentración 50 Inhibidora
Inhibitory Concentration 50
Relación Estructura-Actividad
Structure-Activity Relationship
Rights
openAccess
License
http://purl.org/coar/access_right/c_abf2
id UDEA2_703cadf4ceb8b3965a8e72910869a0ba
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/26424
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures
title Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures
spellingShingle Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures
Plasmodium falciparum
Simulación de Dinámica Molecular
Molecular Dynamics Simulation
Antimaláricos
Antimalarials
Cisteína Endopeptidasas
Cysteine Endopeptidases
Concentración 50 Inhibidora
Inhibitory Concentration 50
Relación Estructura-Actividad
Structure-Activity Relationship
title_short Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures
title_full Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures
title_fullStr Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures
title_full_unstemmed Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures
title_sort Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures
dc.creator.fl_str_mv Hernández González, Jorge Enrique
Salas Sarduy, Emir
Hernández Ramírez, Luisa Fernanda
Pascual, María José
Álvarez, Diego
Pabón Vidal, Adriana
Leitea, Vitor Barbanti
Pascuttie, Pedro
Valiente, Pedro
dc.contributor.author.none.fl_str_mv Hernández González, Jorge Enrique
Salas Sarduy, Emir
Hernández Ramírez, Luisa Fernanda
Pascual, María José
Álvarez, Diego
Pabón Vidal, Adriana
Leitea, Vitor Barbanti
Pascuttie, Pedro
Valiente, Pedro
dc.subject.decs.none.fl_str_mv Plasmodium falciparum
Simulación de Dinámica Molecular
Molecular Dynamics Simulation
Antimaláricos
Antimalarials
Cisteína Endopeptidasas
Cysteine Endopeptidases
Concentración 50 Inhibidora
Inhibitory Concentration 50
Relación Estructura-Actividad
Structure-Activity Relationship
topic Plasmodium falciparum
Simulación de Dinámica Molecular
Molecular Dynamics Simulation
Antimaláricos
Antimalarials
Cisteína Endopeptidasas
Cysteine Endopeptidases
Concentración 50 Inhibidora
Inhibitory Concentration 50
Relación Estructura-Actividad
Structure-Activity Relationship
description ABSTRACT: Background: Falcipain 2 (FP-2) is the hemoglobin-degrading cysteine protease of Plasmodium falciparum most extensively targeted to develop novel antimalarials. However, no commercial antimalarial drugs based on FP-2 inhibition are available yet due to the low selectivity of most FP-2 inhibitors against the human cysteine proteases. Methods: A structure-based virtual screening (SVBS) using Maybridge HitFinder™ compound database was conducted to identify potential FP-2 inhibitors. In vitro enzymatic and cell-growth inhibition assays were performed for the top-scoring compounds. Docking, molecular dynamics (MD) simulations and free energy calculations were employed to study the interaction of the best hits with FP-2 and other related enzymes. Results and conclusions: Two hits based on 4-(9H-fluoren-9-yl) piperazin-1-yl) methanone scaffold, HTS07940 and HTS08262, were identified as inhibitors of FP-2 (half-maximal inhibitory concentration (IC50) = 64 μM and 14.7 μM, respectively) without a detectable inhibition against the human off-target cathepsin K (hCatK). HTS07940 and HTS08262 inhibited the growth of the multidrug-resistant P. falciparum strain FCR3 in culture (half-maximal inhibitory concentrations (IC50) = 2.91 μM and 34 μM, respectively) and exhibited only moderate cytotoxicity against HeLa cells (Half-maximal cytotoxic concentration (CC50) = 133 μM and 350 μM, respectively). Free energy calculations reproduced the experimental affinities of the hits for FP-2 and explained the selectivity with respect to hCatK. General significance: To the best of our knowledge, HTS07940 stands among the most selective FP-2 inhibitors identified by SBVS reported so far, displaying moderate antiplasmodial activity and low cytotoxicity against human cells. Hence, this compound constitutes a promising lead for the design of more potent and selective FP-2 inhibitors.
publishDate 2018
dc.date.issued.none.fl_str_mv 2018
dc.date.accessioned.none.fl_str_mv 2022-03-06T20:53:33Z
dc.date.available.none.fl_str_mv 2022-03-06T20:53:33Z
dc.type.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.hasversion.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.local.spa.fl_str_mv Artículo de investigación
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Hernández-González JE, Salas-Sarduy E, Hernández Ramírez LF, Pascual MJ, Álvarez DE, Pabón A, Leite VBP, Pascutti PG, Valiente PA. Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures. Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2911-2923. doi: 10.1016/j.bbagen.2018.09.015.
dc.identifier.issn.none.fl_str_mv 0304-4165
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10495/26424
dc.identifier.doi.none.fl_str_mv 10.1016/j.bbagen.2018.09.015
dc.identifier.eissn.none.fl_str_mv 1872-8006
identifier_str_mv Hernández-González JE, Salas-Sarduy E, Hernández Ramírez LF, Pascual MJ, Álvarez DE, Pabón A, Leite VBP, Pascutti PG, Valiente PA. Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures. Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2911-2923. doi: 10.1016/j.bbagen.2018.09.015.
0304-4165
10.1016/j.bbagen.2018.09.015
1872-8006
url http://hdl.handle.net/10495/26424
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Biochim. Biophys. Acta, Gen. Subj.
dc.rights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.accessrights.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.creativecommons.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.format.extent.spa.fl_str_mv 13
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier
dc.publisher.group.spa.fl_str_mv Grupo Malaria
dc.publisher.place.spa.fl_str_mv Amsterdam, Paises Bajos
institution Universidad de Antioquia
bitstream.url.fl_str_mv http://bibliotecadigital.udea.edu.co/bitstream/10495/26424/2/license.txt
http://bibliotecadigital.udea.edu.co/bitstream/10495/26424/1/Hern%c3%a1ndezLuisa_2018_Falcipain2PlasmodiumFalciparum.pdf
bitstream.checksum.fl_str_mv 8a4605be74aa9ea9d79846c1fba20a33
32b75fa06581d335581802120d973322
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad de Antioquia
repository.mail.fl_str_mv andres.perez@udea.edu.co
_version_ 1812173257302867968
spelling Hernández González, Jorge EnriqueSalas Sarduy, EmirHernández Ramírez, Luisa FernandaPascual, María JoséÁlvarez, DiegoPabón Vidal, AdrianaLeitea, Vitor BarbantiPascuttie, PedroValiente, Pedro2022-03-06T20:53:33Z2022-03-06T20:53:33Z2018Hernández-González JE, Salas-Sarduy E, Hernández Ramírez LF, Pascual MJ, Álvarez DE, Pabón A, Leite VBP, Pascutti PG, Valiente PA. Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures. Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2911-2923. doi: 10.1016/j.bbagen.2018.09.015.0304-4165http://hdl.handle.net/10495/2642410.1016/j.bbagen.2018.09.0151872-8006ABSTRACT: Background: Falcipain 2 (FP-2) is the hemoglobin-degrading cysteine protease of Plasmodium falciparum most extensively targeted to develop novel antimalarials. However, no commercial antimalarial drugs based on FP-2 inhibition are available yet due to the low selectivity of most FP-2 inhibitors against the human cysteine proteases. Methods: A structure-based virtual screening (SVBS) using Maybridge HitFinder™ compound database was conducted to identify potential FP-2 inhibitors. In vitro enzymatic and cell-growth inhibition assays were performed for the top-scoring compounds. Docking, molecular dynamics (MD) simulations and free energy calculations were employed to study the interaction of the best hits with FP-2 and other related enzymes. Results and conclusions: Two hits based on 4-(9H-fluoren-9-yl) piperazin-1-yl) methanone scaffold, HTS07940 and HTS08262, were identified as inhibitors of FP-2 (half-maximal inhibitory concentration (IC50) = 64 μM and 14.7 μM, respectively) without a detectable inhibition against the human off-target cathepsin K (hCatK). HTS07940 and HTS08262 inhibited the growth of the multidrug-resistant P. falciparum strain FCR3 in culture (half-maximal inhibitory concentrations (IC50) = 2.91 μM and 34 μM, respectively) and exhibited only moderate cytotoxicity against HeLa cells (Half-maximal cytotoxic concentration (CC50) = 133 μM and 350 μM, respectively). Free energy calculations reproduced the experimental affinities of the hits for FP-2 and explained the selectivity with respect to hCatK. General significance: To the best of our knowledge, HTS07940 stands among the most selective FP-2 inhibitors identified by SBVS reported so far, displaying moderate antiplasmodial activity and low cytotoxicity against human cells. Hence, this compound constitutes a promising lead for the design of more potent and selective FP-2 inhibitors.COL000752413application/pdfengElsevierGrupo MalariaAmsterdam, Paises Bajosinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc-nd/4.0/Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum culturesPlasmodium falciparumSimulación de Dinámica MolecularMolecular Dynamics SimulationAntimaláricosAntimalarialsCisteína EndopeptidasasCysteine EndopeptidasesConcentración 50 InhibidoraInhibitory Concentration 50Relación Estructura-ActividadStructure-Activity RelationshipBiochim. Biophys. Acta, Gen. Subj.Biochimica et Biophysica Acta - General Subjects29112923186212LICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://bibliotecadigital.udea.edu.co/bitstream/10495/26424/2/license.txt8a4605be74aa9ea9d79846c1fba20a33MD52ORIGINALHernándezLuisa_2018_Falcipain2PlasmodiumFalciparum.pdfHernándezLuisa_2018_Falcipain2PlasmodiumFalciparum.pdfArtículo de investigaciónapplication/pdf1986151http://bibliotecadigital.udea.edu.co/bitstream/10495/26424/1/Hern%c3%a1ndezLuisa_2018_Falcipain2PlasmodiumFalciparum.pdf32b75fa06581d335581802120d973322MD5110495/26424oai:bibliotecadigital.udea.edu.co:10495/264242022-03-06 15:53:33.55Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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